Quince Therapeutics, Inc. (QNCX)

0.08 -0.01 (-8.78%) USD  |  NASDAQ  |  Mar 20, 16:00
0.085 0.00 (0.00%) After-Hours: 20:00
More

Quince Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for QNCX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Recursion Pharmaceuticals, Inc. Upgrade
Ocular Therapeutix, Inc. Upgrade
Gossamer Bio, Inc. Upgrade
Ernexa Therapeutics, Inc. Upgrade
Acurx Pharmaceuticals, Inc. Upgrade